| Primary information |
|---|
| ID | 13916 |
| Uniprot ID | P01042 |
| Description | Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into- Secretoneurin (SN); Manserin] |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | secreted |
| Developmental Stage | NA |
| Similarity | Bradykinin family |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Influence in smooth muscle contraction;induction of hypotension;natriuresis and diuresis;decrease in blood glucose level;it is a mediator of inflammation and causes ; increase in vascular permeability;stimulation of nociceptors ; release of other mediators of inflammation ; it has a cardioprotective effect |
| Length | 617 |
| Molecular Weight | 70 |
| Name | Bradykinin |
| Sequence | RPPGFSPFR |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | P46663; P30411; P46663; P30411 |
| Domain | NA |
| Pharmaceutical Use | NA
|